Hepatitis B virus markers and antibodies to hepatitis C virus in Japanese patients with hepatocellular carcinoma

scientific article published on January 1, 1992

Hepatitis B virus markers and antibodies to hepatitis C virus in Japanese patients with hepatocellular carcinoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/BF01308344
P953full work available at URLhttp://link.springer.com/content/pdf/10.1007/BF01308344.pdf
http://link.springer.com/article/10.1007/BF01308344/fulltext.html
http://link.springer.com/content/pdf/10.1007/BF01308344
P698PubMed publication ID1309450

P2093author name stringH. Hagiwara
N. Hayashi
H. Fusamoto
T. Kamada
K. Katayama
A. Kasahara
N. Yuki
P2860cites workIsolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genomeQ27860719
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitisQ27860909
Hepatitis C virus infection is associated with the development of hepatocellular carcinomaQ28131791
Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitisQ29547897
A trans-activator function is generated by integration of hepatitis B virus preS/S sequences in human hepatocellular carcinoma DNA.Q31010141
Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assayQ33829664
Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in TaiwanQ34054719
State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver diseasesQ35388339
Hepatitis B virus DNA detected in formalin-fixed liver specimens and its relation to serologic markers and histopathologic features in chronic liver diseaseQ35835318
Transcriptional trans-activating function of hepatitis B virus.Q36919564
Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitisQ37683322
Australia antigen in Singapore Chinese patients with hepatocellular carcinoma and comparison groups: influence of technique sensitivity on differential frequenciesQ38895227
Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinomaQ39243681
Hepatitis B and primary hepatocellular carcinoma in a European populationQ39520598
Antibody to hepatitis B core antigen in patients with hepatocellular carcinomaQ40065690
Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trialQ41839327
Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trialQ42008293
The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivatorQ42631282
Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virusQ42987918
Hepatocellular carcinoma with normal adjacent liver. Hepatitis B virus DNA statusQ43802710
The HBV X-ORF encodes a transactivator: a potential factor in viral hepatocarcinogenesis.Q44779333
A prospective study on the development of hepatocellular carcinoma from liver cirrhosis with persistent hepatitis B virus infectionQ45694032
Hepatitis B Viral Nucleotide Sequences in Non-A, Non-B or Hepatitis B Virus-Related Chronic Liver DiseaseQ45796566
Evidence that hepatitis B virus has a role in liver-cell carcinoma in alcoholic liver disease.Q45800369
Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimensQ45801485
Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigenQ45839143
A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated stateQ45840310
Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinomaQ45844527
Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosisQ45844531
Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigenQ45849086
Infectivity of blood seropositive for hepatitis C virus antibodiesQ45853630
A case/control study of the association between primary liver cancer and hepatitis b infection in senegalQ46707377
Hepatitis C-associated hepatocellular carcinomaQ68477913
Hepatocellular carcinoma after non-A, non-B posttransfusion hepatitisQ72395704
Primary hepatocellular carcinoma following non-A, non-B posttransfusion hepatitisQ72711744
Natural history of hepatitis-associated antigen-positive chronic liver diseaseQ93731683
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectantibodyQ79460
physiologyQ521
hepatitis CQ154869
Hepatitis B virusQ6844
Hepatitis C virusQ708693
viral nonstructural proteinsQ4354558
viral antigensQ66058032
P304page(s)65-72
P577publication date1992-01-01
P1433published inDigestive Diseases and SciencesQ15716711
P1476titleHepatitis B virus markers and antibodies to hepatitis C virus in Japanese patients with hepatocellular carcinoma
P478volume37

Reverse relations

cites work (P2860)
Q43039265Antibodies to hepatitis C virus and hepatitis C virus infection
Q42994894Clinical significance of prior hepatitis B virus infection in patients with hepatitis C virus-related hepatocellular carcinoma
Q27469317Evidence for hepatitis C viral infection in patients with primary hepatocellular carcinoma
Q42981930HCV RNA and antibody to HCV core protein in Japanese patients with chronic liver disease
Q42982050Hepatitis B and C virus and hepatocellular carcinoma
Q43994895Hepatitis B or C virus serology as a prognostic factor in patients with hepatocellular carcinoma
Q42978560Hepatitis C biochemical remission and viral replication in haemodialysis patients
Q36135489Hepatitis C virus RNA in southern African blacks with hepatocellular carcinoma
Q43036518Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patients
Q43039375High prevalence of hepatitis B and C viral markers in Japanese patients with hepatocellular carcinoma
Q43036346IgG and IgM core antibodies and viral replication in hepatitis C virus carriers
Q42983206Immunohistochemical detection of hepatitis C virus-infected hepatocytes in chronic liver disease with monoclonal antibodies to core, envelope and NS3 regions of the hepatitis C virus genome
Q42996626Influence of transfusion-transmitted virus infection on the clinical features and response to interferon therapy in Japanese patients with chronic hepatitis C.
Q42979264Minor role of hepatitis B and C virus infection in the etiology of hepatocellular carcinoma in a low-endemic area
Q45783258Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer
Q43048269Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease
Q43047962Quantitative analysis of hepatitis C virus RNA: relationship between the replicative level and the various stages of the carrier states or the response to interferon therapy
Q40591268Renal manifestations of hepatitis C virus infection
Q35543614Rising incidence of hepatocellular carcinoma: the role of hepatitis B and C; the impact on transplantation and outcomes
Q43041423Serial quantitative analysis of serum hepatitis C virus RNA level in patients with acute and chronic hepatitis C.
Q43048384Serodiagnosis of chronic hepatitis C in Japan by second-generation recombinant immunoblot assay
Q39524313Tropical aspects of viral hepatitis. Hepatitis C.

Search more.